Permanens Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Buy
+316
New +$323K 0.04% 79
2021
Q3
Sell
-100
Closed -$23K 80
2021
Q2
$23K Hold
100
﹤0.01% 71
2021
Q1
$19K Hold
100
﹤0.01% 90
2020
Q4
$17K Hold
100
﹤0.01% 94
2020
Q3
$15K Hold
100
0.01% 88
2020
Q2
$16K Hold
100
0.01% 79
2020
Q1
$14K Sell
100
-263
-72% -$36.1K ﹤0.01% 84
2019
Q4
$48K Buy
363
+263
+263% +$30.5K 0.01% 79
2019
Q3
$11K Hold
100
﹤0.01% 72
2019
Q2
$11K Hold
100
﹤0.01% 71
2019
Q1
$13K Buy
+100
New +$12.2K ﹤0.01% 68

Other funds holding LLY

Permanens Capital's LLY Position: Q2 2026 in Review

Permanens Capital opened a new position in Eli Lilly (LLY) in Q2 2026: 316 shares worth $379K. The stake represents 0.04% of the portfolio and ranks #79 among its holdings. This is a return to the name: Permanens Capital previously reported a position in LLY as recently as Q2 2021.

Permanens Capital first reported a position in LLY in Q1 2019 and has held it in 11 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Permanens Capital held 316 shares of Eli Lilly worth $379K as of Q2 2026.
  • Eli Lilly was a new Permanens Capital position in Q2 2026.
  • Eli Lilly made up 0.04% of Permanens Capital's portfolio in Q2 2026, its #79 holding.
  • Permanens Capital first reported a position in Eli Lilly in Q1 2019 and has held it in 11 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Permanens Capital's 13F filing for Q2 2026, filed 14 Aug 2026.